Sort
48,018 grants matching “immunotherapy”
ADULT AIDS CLINICAL TRIALS UNIT
$1,526,915Judith Ann Aberg · New York University School Of Medicine · U01 · FY2006 · AI
Developing Immune Based Therapies
$1,526,231Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Clinical Program in Pediatric Sarcomas
$1,526,231Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Expanding CAR T cell applications through high-throughput forward- and reverse immune engineering
$1,525,500Mark Yarmarkovich · New York University School Of Medicine · DP2 · FY2024 · CA
Immune Basis & Clinical implications of Threshold-Based Phenotypes of Peanut Allergy
$1,524,997Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
Immune Basis & Clinical implications of Threshold-Based Phenotypes of Peanut Allergy
$1,524,744Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · U19 · FY2022 · AI
Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions
$1,523,795Rafael Meza · Provincial Health Services Authority · U01 · FY2023 · CA
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$1,523,677Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2010 · CA
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
$1,522,830Alon Herschhorn · University Of Minnesota · U01 · FY2024 · AI
Characterization of Biological Nanoparticle Subsets
$1,522,674Jennifer Jones · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Immune Regulation in Mycobacterial and Fungal Infections
$1,521,960Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,521,291Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,521,291Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
ANTIGEN DELIVERY FOR ADJUVANT HIV IMMUNOTHERAPY
$1,520,888University Of Pittsburgh At Pittsburgh · P01 · FY2000 · AI
Heterodimeric IL-15 in Cancer Immunotherapy
$1,519,604George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Immunotherapeutic Approaches for AIDS
$1,519,604George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Immunoglobulin Light Chain Fibrillogenesis
$1,517,567Boston University Medical Campus · P01 · FY2003 · HL
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
$1,516,688David E Fisher · Massachusetts General Hospital · P01 · FY2019 · CA
Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer
$1,516,118Angelo Michael De Marzo · Johns Hopkins University · U54 · FY2025 · CA
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
$1,516,089Melanie Hayden Gephart · Stanford University · U54 · FY2022 · CA
Dendritic cells heterogeneity and function
$1,516,070Roxane Tussiwand · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Cancer Immunotherapy Clinical Trials
$1,516,058Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Induction of autophagy to enhance CAR-T cells in HIV cure approaches
$1,515,431Anjie Zhen · University Of California Los Angeles · R01 · FY2025 · AI
Cytokines and T Cell Development
$1,514,192Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Multiscale Analysis of Immune Responses
$1,513,316Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI